TPG Explores Five Billion Sale of Lyric
Private equity firm TPG is exploring a sale of healthcare software company Lyric. The deal could value the payments firm at approximately five billion dollars. TPG is working with investment bankers at JPMorgan Chase on the potential transaction.
Xurve View
Insights:
Xurve View
TPG INC is exploring a sale of healthcare software provider Lyric that could value the business at about $5B, people close to the matter said during late evening hours on Tuesday. The process signals a rebound in software dealmaking following a sector-wide selloff triggered by artificial intelligence concerns. Insurers including UNITEDHEALTH GROUP INC, CVS HEALTH CORP, and HUMANA INC rely on Lyric to manage and prevent inaccurate claims payments.
